Delivery Order SPE2DB22D9367-SPE2DB25FSX01

Award Date 3/6/25
Potential Completion Date 3/27/25
Potential Value $31K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $10,415.40, is for the delivery of Mirena 52 mg systems, a type of intrauterine device (IUD). This delivery order was issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, which allows the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,323.84, is for the delivery of Mirena 52 mg systems, a type of intrauterine device (IUD). The contract is a firm fixed-price delivery order with a period of performance through November 15, 2023. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,603.85, is for the delivery of Mirena 52 mg systems, a type of intrauterine device. The contract has an ultimate completion date of March 25, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,552 delivery order is for the supply of Mirena 52 mg systems, a hormonal intrauterine device used for contraception. The contract is placed under DMS Pharmaceutical Group's $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA, which allows the agency to issue firm...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg systems, a type of intrauterine device, and has a ceiling value of $2,083.12. The contract is not associated with any set-aside designation and has an ultimate completion date of February 4, 2025. DMS Pharmaceutical Group Inc. has a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $15,623.10 contract is for the delivery of Mirena 52 mg systems, which are intrauterine devices used for contraception. The contract has an ultimate completion date of February 7, 2025. DMS Pharmaceutical Group Inc. holds a large Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,207.70, is for the delivery of Mirena 52 mg systems, a type of intrauterine device (IUD). The contract has an ultimate completion date of February 5, 2025. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,960.00, is for the delivery of Mirena 52 mg systems, a type of intrauterine contraceptive device. The contract has an ultimate completion date of July 30, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg Systems, a hormonal intrauterine device, at a firm fixed price of $2,368.00. The contract has an ultimate completion date of December 27, 2024, and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $26,038.50 contract is for the delivery of Mirena 52 mg systems, a type of intrauterine device, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
  • SPE2DB22D9367
    Indefinite Delivery Contract
  • SPE2DB22D9367-SPE2DB25FSX01
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $31,246.20, is for the delivery of Mirena 52 mg systems, a type of intrauterine device (IUD). The contract has an ultimate completion date of March 27, 2025. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This delivery order contract is not associated with any set-aside designation.

Generated 6/5/25, 10:09 AM